FEASIBILITY AND SAFETY OF LONG-TERM INTRATHECAL PSEUDODELIVERY OF IMMUNOTHERAPY FOR SELECTIVE CLEARANCE OF CSF AMYLOID-Β IN A MOUSE MODEL OF ALZHEIMER’S DISEASE | Publicación